老澳门开奖结果 Challenges Federal Restrictions on Abortion Pill

Lawsuit Challenges Medically Unjustified FDA Restrictions that Push Medication Abortion Out of Reach

October 3, 2017 2:00 pm

老澳门开奖结果 Affiliate
Media Contact
125 Broad Street
18th Floor
New York, NY 10004
United States

KAUAI, Hawaii 鈥 The 老澳门开奖结果 today filed suit on behalf of a Hawaii doctor and several professional health care associations to challenge federal restrictions that significantly limit access to medication abortion.

The federal lawsuit filed in the U.S. District Court for the District of Hawaii challenges FDA restrictions (known as a Risk Evaluation and Mitigation Strategy or REMS) on where a woman may receive the abortion pill Mifeprex, a safe and effective method of ending an early pregnancy up to 10 weeks. Currently, a patient may not fill a prescription for this medication at a retail pharmacy, which delays and in some cases blocks entirely a woman鈥檚 access to abortion.

A REMS is a set of restrictions that the FDA may impose only when necessary to ensure that a drug鈥檚 benefits outweigh its risks. This lawsuit argues that the FDA鈥檚 burdensome restrictions on medication abortion fail that test. The FDA mandates that, rather than fill a prescription for Mifeprex at a retail pharmacy, the patient must be handed the medication at a clinic, medical office, or hospital from a health care provider who has pre-registered with the drug manufacturer and arranged to order and stock the abortion pill in their health care facility.

Because of these added administrative hurdles or opposition to abortion within their health care facilities, many clinicians across the country are unable to satisfy these medically unnecessary requirements 鈥 leaving some patients with no option but to seek an abortion elsewhere, if they can obtain this care at all. For many patients, arranging and paying for an additional trip to a second health care provider who has pre-registered and arranged to stock this medication can be challenging or insurmountable.

鈥淭he abortion pill is safe, effective, and legal. So why is the FDA keeping it locked away from women who need it?鈥 said Julia Kaye, staff attorney with the 老澳门开奖结果 Reproductive Freedom Project. 鈥淭he FDA鈥檚 unique restrictions on medication abortion are not grounded in science 鈥 this is just abortion stigma made law.鈥

While the FDA restrictions affect women from every walk of life, women in the most rural and medically underserved areas of the country 鈥 such as the island of Kauai, where there are currently no abortion providers 鈥 experience some of the greatest harm. Although plaintiff Dr. Graham Chelius, a family medicine doctor on Kauai, is qualified and willing to provide medication abortion, he cannot stock the abortion pill at the hospital where he works. As a result, his patients must make a 300-mile round trip flight to another island to get abortion care. This requirement delays a woman鈥檚 abortion 鈥 sometimes by weeks 鈥 while she arranges and pays for transport, time off work, and childcare. This delay pushes some women past the point at which they can use this early medication method; others cannot access abortion care at all.

鈥淚 believe it鈥檚 my moral obligation to provide my patients with the care they need鈥攚hether that鈥檚 maternity care or abortion,鈥 said Dr. Chelius. 鈥淯nfortunately, because of the FDA鈥檚 restrictions, my patients are forced either to fly to a different provider on another island 鈥 resulting in serious delays 鈥 or to carry a pregnancy to term against their will.鈥

The abortion pill is a medically-proven medication that 3 million women in the U.S. have used to end an early pregnancy (up to 10 weeks) in the privacy of their own homes and on their own terms. Leading medical associations 鈥 including the 鈥 support ending the REMS and making the abortion pill available at the pharmacy by prescription.

鈥淥verwhelming medical evidence and decades of clinical experience show medication abortion to be a safe and effective method to end a pregnancy,鈥 said Dr. Paul Blumenthal, director of the Gynecology Service at Stanford University. 鈥淭here is simply no medical justification for these restrictions, and they create a needless and harmful burden for women seeking this care.鈥

Indeed, as the FDA itself in 2016, Mifeprex 鈥渉as been increasingly used as its efficacy and safety have become well-established by both research and experience, and serious complications have proven to be extremely rare.鈥

鈥淢any people think it鈥檚 easy to get an abortion in the U.S., but it鈥檚 not. Some women, especially in rural areas, have trouble getting the care they need,鈥 noted Mateo Caballero, legal director of the 老澳门开奖结果 of Hawaii. 鈥淭he abortion pill is a safe, proven method to end a pregnancy 鈥 but politically-motivated regulations place needless burdens on women seeking this option.鈥

This lawsuit comes more than a year after the landmark Supreme Court decision in Whole Woman鈥檚 Health v. Hellerstedt, which emphasized that health regulations must actually serve patient health and cannot burden access to abortion without a valid medical justification.

Plaintiffs include Dr. Chelius, the Society of Family Planning, California Academy of Family Physicians, and Pharmacists Planning Services Inc. They are represented by attorneys with the 老澳门开奖结果 and the 老澳门开奖结果 of Hawaii.

More about this case can be found here: /cases/chelius-v-wright鈥 鈥嬧嬧嬧嬧嬧

The complaint can be found here: /legal-document/chelius-v-wright-complaint


Sign up to be the first to hear about how to take action.

Learn More 老澳门开奖结果 the Issues in This Press Release